News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Investing.com Nigeria Market update
This article reports on ABVC Biopharma Inc.'s Form 8K filing for August 12. The filing is a standard requirement for publicly traded companies to announce significant events that shareholders should know. The article provides the title of the filing and mentions the company's stock symbol and a slight decrease in its share price.
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides an earnings forecast for ABVC Biopharma Inc (ABVC), focusing on future EPS and revenue growth estimates. It includes current stock information, market capitalization, and a peer comparison from the biotechnology and medical research sector. The forecast sections cover expected EPS, revenue, …
This article from TradingKey provides current stock information for BitVentures American Depositary Shares (BVC), including its recent trading price, market cap, and links to financial data and news. It indicates that more news will be coming soon for the company.
This article provides the current stock news and financial overview for ABVC Biopharma Inc (ABVC). It highlights the company's stock performance, market capitalization, and various financial and analytical tools available on the TradingKey platform. The article also indicates that more news will be coming …
ABVC BioPharma, Inc. (NASDAQ: ABVC) has postponed the distribution of BioKey (Cayman), Inc. ordinary shares, originally set for August 3, 2026, due to pending administrative, regulatory, and tax matters. While the record date and distribution ratio remain unchanged, the ex-dividend date will be reset …
ABVC Biopharma has postponed the planned August 3 distribution of BioKey ordinary shares to address administrative, regulatory, and tax matters. The distribution ratio of 0.169464 BioKey shares per ABVC common share and the record date remain unchanged. ABVC will announce new distribution and ex-dividend …
The article provides a technical analysis and stock price forecast for BitVentures Ltd (BVC), indicating a "Strong Buy" consensus based on various technical indicators and moving averages. It highlights that BVC is trading above its key moving averages, with specific support and resistance levels …
This article provides a risk assessment for ABVC Biopharma Inc (ABVC), noting its current risk score of 3.01 and ranking within the Biotechnology & Medical Research industry. It details the company's beta value of 0.54, indicating lower volatility compared to the S&P 500, and …
This article focuses on the valuation of BitVentures American Depositary Shares (BVC), providing an overview of its market capitalization, current trading price, and key financial metrics like P/E TTM. It highlights the stock's recent performance and offers various sections for in-depth analysis, including news, …
This article provides a technical analysis of BitVentures American Depositary Shares (BVC), detailing various indicators and moving averages. While certain indicators like CCI, Williams %R, TRIX, and StochRSI suggest a sell signal, all listed moving averages (MA5 to MA200) indicate a buy signal, leading …
This article provides an income statement overview for BitVentures American Depositary Shares (BVC), detailing key financial metrics and offering FAQs on how to interpret them. It highlights BVC's net income of -5.37M and operating income of -3.69M for fiscal year 2025. The content aims …
ABVC BioPharma is holding a virtual special shareholder meeting on September 18, 2026, to vote on three key proposals. These include approving a new 2026 Equity Incentive Plan, ratifying equity awards granted after February 16, 2026, and authorizing the issuance of up to 6,638,591 …
This article provides an overview of ABVC Biopharma Inc's (ABVC) dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years and lists several merger-related stock splits that occurred on July 24, 2023, each …
This article provides a detailed cash flow statement for ABVC Biopharma Inc (ABVC), encompassing quarterly and annual data for operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flow and their significance for the company's financial health. …
This article provides a revenue breakdown for BitVentures American Depositary Shares (BVC), detailing its business segments. As of the updated information, the company generated $24.10M from Wealth Management (86.02%) and $3.92M from Assets Management (13.98%). Further regional and profit contribution data have not yet …
This article from TradingKey provides a revenue breakdown for ABVC Biopharma Inc (ABVC), detailing its business segments, regional revenue, and profit contribution. However, the data has not been disclosed by the company yet, indicating a lack of publicly available information on these specific financial …
This article provides a technical analysis of ABVC Biopharma Inc (ABVC), noting its current stock price momentum score is 5.98, ranking 29th in its industry. The stock is trading between a resistance level of 1.79 and a support level of 0.60, suggesting suitability for …
The article analyzes the institutional confidence in ABVC Biopharma Inc (ABVC), noting its current institutional shareholding score of 3.00, placing it 192nd in its industry. Institutional ownership stands at 3.41%, an increase of 1.88% quarter-over-quarter. James Simons is identified as the largest institutional shareholder, …
This article provides an analysis of BitVentures American Depositary Shares' (BVC) cash flow, detailing its operating, investing, and financing activities. It highlights BVC's -6.48M operating cash flow in fiscal 2025, 2.00K spent on capital expenditures, and 1.01M used in financing activities in the latest …
This article details the shareholder structure of BitVentures American Depositary Shares (BVC), identifying major shareholders like Carmel Holdings Limited (71.28%) and XTX Markets LLC (0.29%). It breaks down shareholding by type, showing that corporations hold the largest proportion. The report also includes institutional shareholding …
This article provides the comprehensive balance sheet for ABVC Biopharma Inc (ABVC), presenting both quarterly and annual financial data. It details assets, liabilities, and shareholders' equity over multiple fiscal years, allowing users to analyze the company's financial health, liquidity, leverage, and return on equity. …
This article provides real-time quotes, trading strategies, and related analysis for BitVentures American Depositary Shares (BVC). It includes key financial figures, performance over various periods, technical indicators, and shareholder information. The current price of BVC is 10.650 USD, marking a -3.18% change, with a …
This article provides a valuation analysis of ABVC Biopharma Inc (ABVC), noting its current valuation score is 7.27, ranking 241 out of 386 in its industry. It highlights the company's P/E ratio of -2.56, but points out that key data for P/B, P/S, and …
This article provides details on the shareholder structure of ABVC Biopharma Inc (ABVC), outlining the major individual and corporate shareholders, as well as institutional holdings. It lists the proportion of shares held by key entities like Jiang (Shuling) and YuanGene, Corp, along with data …
This article presents the quarterly and annual income statements for ABVC Biopharma Inc (ABVC), offering detailed financial data on various metrics such as total revenue, operating expenses, and net income. It also includes an FAQ section explaining how to interpret the income statement and …
This page provides a comprehensive overview of BitVentures Limited (BVC) stock, including its current price, historical data, and key financial metrics. It details the company's business in developing early-stage technology businesses, offering client referral services, and providing various insurance products. The article also presents …
ABVC Biopharma Inc. (ABVC) is a clinical-stage biopharmaceutical company focused on developing therapies for various diseases, with its stock currently trading at $1.15, down 4.17%. Despite recent weak stock performance, the company's fundamentals are stable, and its growth potential is considered high. Analysts view …
BitVentures Limited รายงานผลประกอบการทางการเงินและพัฒนาการทางธุรกิจประจำครึ่งปีแรกของปีงบประมาณ 2026. บริษัทได้กล่าวถึงกิจกรรมทางธุรกิจและความก้าวหน้าในช่วงครึ่งปีที่ผ่านมา.
Search by ticker symbol or company name and select a result to open its chart.